Jude F. N. Rodrigues

Suggest Changes
Learn More
OBJECTIVE This study compared the efficacy and tolerability of the cyclooxygenase-2-selective inhibitor valdecoxib with the nonselective NSAID naproxen and with placebo in treating severe rheumatoid(More)
  • 1